Why Nutrition Matters in Oncology
Malnutrition is a common and serious complication in individuals with cancer. It can impair immune function, reduce tolerance to treatment, worsen quality of life, and increase mortality. Early detection and intervention are therefore essential components of comprehensive cancer care.
Key Objectives of Nutritional Assessment
- Identify patients at risk of, or already experiencing, malnutrition.
- Quantify the severity of nutritional deficits.
- Guide individualized nutrition therapy.
- Monitor changes over the course of treatment.
Core Components of the Assessment
A thorough assessment blends clinical judgment with validated tools. The main elements include:
1. Medical History and CancerRelated Factors
- Type and stage of cancer.
- Current and planned therapies (surgery, chemotherapy, radiotherapy, immunotherapy).
- Presence of tumorrelated metabolic changes (e.g., cachexia).
2. Anthropometric Measurements
Weight, height, body mass index (BMI), and recent weight change are fundamental. When possible, body composition analysis (e.g., bioelectrical impedance analysis or dualenergy Xray absorptiometry) provides insight into muscle loss.
3. Dietary Intake Evaluation
Methods range from a simple 24hour recall to a 3day food diary. The PatientGenerated Subjective Global Assessment (PGSGA) incorporates intake quality and quantity.
4. Laboratory Markers
Relevant labs include serum albumin, prealbumin, Creactive protein (CRP), and lymphocyte count. While none are definitive on their own, trends help track inflammationrelated catabolism.
5. Functional Status
Handgrip strength, the 6minute walk test, or the sittostand test provide objective data on muscle function, which often declines before weight loss is evident.
6. Symptom Assessment
Symptoms such as nausea, vomiting, dysphagia, mouth sores, and early satiety directly limit intake. Tools like the MD Anderson Symptom Inventory (MDASI) capture their impact.
Validated Screening and Assessment Tools
Below is a concise comparison of the most frequently used instruments.
| Tool | Population | Time Required | Key Domains | Score Interpretation |
|---|---|---|---|---|
| Malnutrition Universal Screening Tool (MUST) | All adults | 5min | BMI, weight loss, acute disease effect | 0 = low risk, 1 = medium, 2 = high |
| PGSGA | Cancer patients | 10min | Weight change, intake, symptoms, activity, disease | A = well nourished, B = moderate, C = severe |
| Mini Nutritional AssessmentShort Form (MNASF) | Elderly (65yr) | 5min | Screening, anthropometry, dietary, global assessment | 1214 = normal, 811 = at risk, 7 = malnourished |
| Nutrition Risk Screening 2002 (NRS2002) | Hospitalised adults | 8min | Severity of disease, impaired intake, weight loss | Score 3 = nutrition risk |
Integrating Assessment into Clinical Workflow
Effective implementation requires coordination among oncologists, nurses, dietitians, and allied health professionals.
- Initial Screening: Perform at the first oncology visit using a rapid tool (e.g., MUST or NRS2002).
- Comprehensive Assessment: If the screen is positive, schedule a full PGSGA or similar evaluation within 48hours.
- Intervention Planning: Based on severity, prescribe oral nutrition supplements, fortified meals, or enteral/parenteral nutrition.
- Followup: Rescreen weekly during active treatment and monthly during survivorship.
Common Challenges and Solutions
- Time Constraints: Use brief screens and delegate data collection to nursing staff.
- Variability in Expertise: Provide training modules on PGSGA and handgrip testing.
- Patient Reluctance: Emphasise the link between nutrition and treatment tolerance during counseling.
- Resource Limitations: Prioritise highrisk groups (e.g., gastrointestinal, headneck, lung cancers) for full assessments.
Conclusion
Nutrition is a modifiable factor that can dramatically affect outcomes for cancer patients. Systematic assessmentstarting with rapid screening and progressing to detailed, multidimensional evaluationenables timely, personalized interventions. Embedding these practices into routine oncology care improves treatment adherence, reduces complications, and enhances quality of life.
